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on chromosome Xp21. Rowland's chapter provides an exciting introduction to what
proves to be a disappointing volume.
Many ofthe chapters which review current advances in a particular disease are too
brief and not well written. For example, a chapter on the construction of a complete
restriction map of human chromosome 19 describes, in less than three pages, the
strategy used to accomplish such a feat. Other chapters, such as the chapter on the
inherited neuropathies and the chapter on the inherited ataxias, present information
which is interesting, but reflects the poor understanding ofthe nature ofmany ofthese
disorders.
Muchofthe workpresented focuses on theidentification ofmarkers for neurological
and neuromuscular disease. Many of the authors use pedigree analysis and the
isolation ofrestriction fragment length polymorphisms (RFLP) to map and screen for
disease. For example, Helmut Zander discusses his search for markers for multiple
sclerosis in families in his native West Germany. The last chapter, by S. Chamberlain,
C. Worrall, and R. Williamson, describes, in less than four pages, their attempts to
map the locus for Friedreich's ataxia (FA); mostofthis chapter focuses on background
information and not on their work, which has ruled out chromosomes 19 and 21 as
possible locations ofthe FA locus.
Thereare a few bright spots in thisvolume. Achapter authored by J.E. Fox and L.E.
Rosenberg describes their discovery of a RFLP at the ornithine transcarbamylase
(OTC) locus, using OTC cDNA probes; in addition, they nicely show how this RFLP
can be used in the prenatal diagnosis ofOTC deficiency, as well as in carrier detection
and carrier exclusion.
Twoother excellent chapters in this bookwere both authored by Kay Tanaka, whose
primary work has been the study of isovaleric acidemia. In these chapters, Tanaka
clearly discusses the biochemical and enzymatic basis for this disorder. He then delves
into his own research, which has shown that this disorder is due to a deficiency of
isovaleryl CoA dehydrogenase activity. After describing the purification and charac-
terization of five different acyl-CoA dehydrogenases, Tanaka brings us to his current
focus on the molecular cloning ofthese five enzymes.
This volume is intended for physicians, scientists, and students interested in the field
ofgenetics and neurology. Pedigree analysis and restriction fragment length polymor-
phisms provide both simple and powerful tools in the study and diagnosis of genetic
disorders. Inexcusably, this volume omits advances in other important areas such as
nerve regeneration, the use of transgenic mice to study multiple sclerosis, and the
cloning and characterization ofreceptors for neurotransmitters.
The book presents an overview of neurological and neuromuscular disorders. Each
chapter provides numerous references so that the reader can pursue relevant literature;
however, this bookfocuses almost entirely on gene mapping and RFLPs anddevotes no
time to other advances in this field engendered by the development of recombinant
DNA technology.
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There are many devastating diseases that afflict the human being, but none more so
than neurological diseases, which strike at the very heart of human existence. An290 BOOK REVIEWS
enormous effort has been devoted to elucidate the nature of these diseases: what is
wrong, what is the cause, why are some afflicted while others are not.... ? As the title
indicates, Functional Recovery in Neurological Disease takes a slightly different
approach and asks: given a damaged nervous system, how does the rest of the system
cope with this deficit, what constitutes functional recovery, and how can the clinician
disrupt the disease process in patients who do not recover?
The book is edited by Stephen Waxman, who is chairman of the Department of
Neurology at Yale as well as director of the Center for Research on Neurological
Diseases at the West Haven Veterans Administration Medical Center. In this volume,
the editor brings together clinicians and basic science researchers to provide a
balanced, up-to-date, and informative account of various aspects of neurological
recovery. The objectives are: "to illustrate the close interrelationship between observa-
tions made at the bedside and those made in the laboratory," and "to review those
aspects ofbasic neuroscience that are most relevant to neurological rehabilitation."
The volume can be divided into two parts. The first part concentrates on recovery in
three fundamental disease processes in the nervous system: axonal injury, demyelinat-
ing diseases, and loss of neurons and synaptic inputs. Specific examples of these
processes include spinal cord injury, multiple sclerosis, and stroke. Each of the three
sections starts with clinical observations followed by a detailed review ofexperimental
findings. The final part of this volume focuses on potential therapeutic interventions.
Feasibility of the use of growth factors, gangliosides, electric fields, and artificial
intelligence in helping patients is carefully examined.
While extensive discussion of various experimental modes of therapy is included,
scant attention is paid to current treatment options. This lack may disappoint the
clinician struggling to maximize the patient function in the here and now; however, the
viewpoint is appropriate, since the book deals with work in progress and emphasizes
areas of future research. Furthermore, the volume may not be easily accessible to a
basic scientist without any clinical exposure. A glossary could have made the book
more accessible by defining terms such as paresthesia or Lhermitte's sign.
Ingeneral, thechapters arewell-written and extensively referenced, the illustrations
are clear, and the organization is excellent. In integrating clinical and experimental
data, this book has indeed accomplished its objectives, providing a realistic evaluation
of recent advances in the field of neurological rehabilitation. At the same time, each
author maintains a pragmatic optimism regarding prospects for future therapies. This
volume should prove to be intellectually stimulating not only to neurologists and
neuroscientists, but also to students fascinated by neuroscience.
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Autoimmune processes are being implicated more and more as either primary or
contributory causes of a wide variety of human pathologies. The phenomenon of
autoimmunity and its significance can be little disputed; however, man's understand-
ingofthis process is still incomplete. Thus, relatively little can bedone to treat affected